Clinical Trials Logo

Skin Inflammation clinical trials

View clinical trials related to Skin Inflammation.

Filter by:

NCT ID: NCT03976206 Withdrawn - Clinical trials for Stem Cell Transplant Complications

Very Small Embryonic-like Stem Cells for Facial Skin Antiaging

Start date: July 6, 2019
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this study is the safety and efficacy of autologous very small embryonic-like stem cells(VSELs) to facial skin antiaging.

NCT ID: NCT03862872 Withdrawn - Inflammation Clinical Trials

Effects of Bend Beauty's Anti-Aging Formula on Inflammatory Markers

BENCHMARK
Start date: February 2020
Phase: N/A
Study type: Interventional

This is a phase IV, randomized, double-blind, placebo-controlled, three-arm, parallel intervention study including three groups of 25 subjects between 35-65 years of age, treated with either Bend Beauty's Anti-Aging Formula, fish oil control or inert placebo for 90 days, with testing points at baseline, 30, 60, and 90 days.

NCT ID: NCT03581747 Recruiting - Atopic Dermatitis Clinical Trials

Detection of Skin Epithelial Barrier in Patients With Allergic Skin Disorders

Start date: August 1, 2018
Phase:
Study type: Observational

The primary function of epithelial tissues is to form a barrier between the body and the external environment, in order to protect the internal tissues from environmental stresses, by minimizing water loss and preventing the entry of pathogens, pollutants and allergens. Allergic disorders, such as atopic dermatitis, have been associated to an impaired epithelial barrier function. Indeed, defects in the epithelial barriers allow tissue-damaging factors to enter the tissue and thus activate the immune response. This study aims to establish a method to assess the epithelial barrier function in vivo by electrical impedance (EI) spectroscopy, a new technique for the characterisation of epithelial tissue. By this technique, a harmless electrical signal is sent through the skin and the response of the tissue is analysed, which is influenced by several cellular properties, such as shape, orientation and size. In order to validate this technique, skin of mice was treated with some molecules able to destroy the epithelial barrier. The investigators observed that, after damaging the barrier, a decrease of the EI can be detected, consistent with the type and degree of the damage. Based on this result, the investigators believe that this technique is a good candidate as an in vivo method to determine skin barrier defects, which might be used in the future as an early diagnostic tool for the prediction of the risk to develop atopic dermatitis in young subjects, allowing the possibility to apply in time possible preventive measures. In addition, this technique might be suitable for the evaluation of a given therapy during the hospitalisation. To confirm this hypothesis, in the present study patients with atopic dermatitis will be recruited. EI measurements will be performed in both lesional and non-lesional skin and values will be compared in order to detect any difference in the electrical response due to the inflammatory state. In addition, in order to evaluate whether these patients have an appreciable defect in their skin electrical behaviour, the investigators will compare non-lesional and lesional skin of patients with skin of healthy volunteers. Peripheral venous blood and skin biopsies will be collected, in oder to characterise several immune cell populations, to detect specific skin barrier mutations and to measure serum cytokines and immunoglobulins. These and some other parameters and will be analysed in order to identify a possible correlation with the EI.

NCT ID: NCT03192280 Completed - Skin Inflammation Clinical Trials

Skin IaM: An Exploratory Clinical Trial to Evaluate Changes in Skin Appearance, Colour, and/or Texture Following the Induction of a Local Inflammatory Skin Response

Start date: June 19, 2017
Phase: N/A
Study type: Interventional

This trial will test the feasibility of various imaging devices to detect local skin inflammation prior to clinical manifestation.

NCT ID: NCT03065504 Completed - Skin Inflammation Clinical Trials

Turmeric and Turmeric-containing Tablets and Sebum Production

Start date: November 2016
Phase: N/A
Study type: Interventional

A noticeably increasing number of patients are asking for naturally based extracts and ingredients as supplementary dermatologic remedies. Patients are seeking natural and cost-effective skin care alternatives in place of prescription medications and procedures. This study will isolate the effects of oral turmeric and assess a combination tablet that includes turmeric on sebum production in healthy subjects.